Identification and characterization of chemotherapy resistant high-risk neuroblastoma persister cells.
Grossmann LD, Chen CH, Uzun Y, Thadi A, Wolpaw AJ, Louault K, Goldstein Y, Surrey LF, Martinez D, Calafatti M, Gerelus M, Gao P, Lee L, Patel K, Kaufman RS, Shani G, Farrel A, Moshitch-Moshkovitz S, Grimaldi P, Shapiro M, Kendsersky NM, Lindsay JM, Casey CE, Krytska K, Scolaro L, Tsang M, Groff D, Matkar S, Kalna JR, Mycek E, McDevitt J, Runbeck E, Patel T, Bernt KM, Asgharzadeh S, DeClerck YA, Mosse YP, Tan K, Maris JM.
Grossmann LD, et al. Among authors: mosse yp.
Cancer Discov. 2024 Jul 31. doi: 10.1158/2159-8290.CD-24-0046. Online ahead of print.
Cancer Discov. 2024.
PMID: 39083807